Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
hb-201 (2 trials)
low dose hb-101 (2 trials)
hb-101 (1 trial)
Carcinoma, Squamous Cell (Phase 2)
Cytomegalovirus Infections (Phase 1)
Oropharyngeal Neoplasms (Phase 1)
Uterine Cervical Neoplasms (Phase 1)
Trials (4 total)
Trial APIs (3 total)